# Asilomar Conference **Domain:** Scientific Governance / Biotechnology / Risk **Doc Type:** Canonical Governance Event Node **Maturity:** Foundational ## Definition The **1975 Asilomar Conference on Recombinant DNA** brought scientists, physicians, lawyers and others together to assess biohazards and propose risk-tiered conditions for recombinant-DNA research. ## What the Precedent Establishes The conference followed calls for temporary restraint on selected experiments and helped shape later NIH guidelines. It demonstrated that a technical community could make uncertainty operational through containment levels and research conditions. [[articles/The Evolutionary Roots of Silicon Valley|The Evolutionary Roots of Silicon Valley]] presents Asilomar as a precedent for frontier AI governance. The analogy must remain bounded. Recombinant-DNA experiments had relatively identifiable laboratory practices and containment variables; contemporary machine systems involve broader actors, diffuse deployment and disputed social harms. ## Rights and Continuity Context The durable lesson is procedural: people exposed to risk need representation, evidence must remain revisable, and voluntary expert norms require public accountability. Builder self-restraint is valuable but cannot substitute indefinitely for legitimate institutions. ## Key Insight **Asilomar's transferable achievement was not a universal moratorium template but the conversion of expert uncertainty into explicit, revisable operating constraints.** ## Sources / Provenance - Paul Berg, “Asilomar and recombinant DNA”: https://www.nobelprize.org/prizes/chemistry/1980/berg/article/ - Stanford Cohen laboratory history: https://med.stanford.edu/sncohenlab/stan-cohen.html ## See Also [[wiki/Recombinant DNA|Recombinant DNA]], [[wiki/Precautionary Principle|Precautionary Principle]], [[wiki/AI Governance|AI Governance]], [[wiki/Transition Consent|Transition Consent]]